T-cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial

Detalles Bibliográficos
Autores principales: Blixt, Lisa, Wullimann, David, Aleman, Soo, Lundin, Jeanette, Chen, Puran, Gao, Yu, Cuapio, Angelica, Akber, Mira, Lange, Joshua, Rivera-Ballesteros, Olga, Buggert, Marcus, Ljunggren, Hans-Gustaf, Hansson, Lotta, Österborg, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968881/
https://www.ncbi.nlm.nih.gov/pubmed/35045694
http://dx.doi.org/10.3324/haematol.2021.280300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968881/
https://www.ncbi.nlm.nih.gov/pubmed/35045694
http://dx.doi.org/10.3324/haematol.2021.280300

Ejemplares similares